Your session is about to expire
← Back to Search
nfant(R) feeding system for Premature Infants
N/A
Waitlist Available
Led By Nanette Gremillion, PT, MS, CNT
Research Sponsored by Woman's
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 33 weeks through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial is testing whether using high-tech monitors during feedings for premature babies will help improve feeding performance and clinical decision making.
Eligible Conditions
- Premature Infants
- Premature Birth
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 33 weeks through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~33 weeks through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of inpatient Modified Barium Swallow Study (MBSS)/repeat MBSS
Number of participants with Full oral feeding
Number of participants with decreased Feeding Related Length of Stay
+6 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: nfant(R) feeding systemExperimental Treatment1 Intervention
Addition of nfant(R) technology, along with visual assessments and cue-based feeding practices, to facilitate an infant's progression to full oral feeding and potentially improve developmentally supportive feeding practices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
nfant(R) feeding system
2020
N/A
~30
Find a Location
Who is running the clinical trial?
NFANT LabsUNKNOWN
Woman'sLead Sponsor
17 Previous Clinical Trials
1,431 Total Patients Enrolled
Nanette Gremillion, PT, MS, CNTPrincipal InvestigatorWoman's Hospital, Louisiana
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How can I register to take part in this experiment?
"This clinical trial seeks 50 neonates born between 22 and 29 weeks gestation. To be eligible, the infants must have been no more than 29 6/7 weeks in utero at birth."
Answered by AI
Does this research endeavor accept participants who are aged 40 and above?
"According to the rules regulating this clinical trial, only individuals between 22 and 29 Weeks of age are allowed to participate."
Answered by AI
Is recruitment for this research endeavor currently underway?
"According to clinicaltrials.gov, this particular trail is not presently recruiting participants as the last update was on May 4th 2022. Nonetheless, 287 other trials are actively seeking enrolment at this time."
Answered by AI
Share this study with friends
Copy Link
Messenger